a fecal immunochemical test (FIT), and a multitarget stool DNA test (MT-sDNA, Exact Sciences Cologuard). The four emerging screening methods were two cf-bDNA tests (Guardant Shield and Freenome ...
At the beginning of October, the FDA approved the Cologuard Plus test, a next-generation, multitarget stool DNA test. While fecal testing is a good option for some patients, colonoscopy remains the ...
Cologuard refers to an at-home stool DNA test that can help screen for colon cancer or polyps. A person enrolled in Medicare aged between 45 and 85 is eligible for coverage for a Cologuard test ...